Anti-platelet drugs attenuate the expansion of circulating CD14(high)CD16(+) monocytes under pro-inflammatory conditions

AIMS: Levels of circulating CD14(high)CD16(+) monocytes increase in atherosclerotic patients and are predictive of future cardiovascular events. Platelet activation has been identified as a crucial determinant in the acquisition of a CD16(+) phenotype by classical CD14(high)CD16(−) cells. We tested...

Descripción completa

Detalles Bibliográficos
Autores principales: Layne, Kerry, Di Giosia, Paolo, Ferro, Albert, Passacquale, Gabriella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909161/
https://www.ncbi.nlm.nih.gov/pubmed/27118470
http://dx.doi.org/10.1093/cvr/cvw089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4909161/
https://www.ncbi.nlm.nih.gov/pubmed/27118470
http://dx.doi.org/10.1093/cvr/cvw089

Ejemplares similares